<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="2" iati-activities:version="2.03" xml:lang="EN" xmlns:gavi="http://gavi.org/" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>47122-ETH-TCA</iati-identifier>
  <reporting-org ref="47122" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Ethiopia: Targeted country assistance</narrative>
   <narrative xml:lang="FR">&#xC9;thiopie (l&apos;): Aide cibl&#xE9;e aux pays</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="FR">L&#x2019;assistance technique est un soutien non financier fourni par des sp&#xE9;cialistes. Elle peut rev&#xEA;tir plusieurs formes : partage d&#x2019;information et de savoir-faire, formation et services-conseils.

L&#x2019;assistance technique fournie dans le cadre du PEF est appel&#xE9;e aide cibl&#xE9;e aux pays. Ce type de soutien vise principalement &#xE0; payer le personnel bas&#xE9; en permanence dans les bureaux pays des partenaires. Il repose sur la demande et les besoins identifi&#xE9;s par les pays eux-m&#xEA;mes.</narrative>
   <narrative xml:lang="EN">Technical assistance is non-financial support provided by specialists. It can take the form of sharing information and expertise, training and consulting services.

The technical assistance provided through PEF is called targeted country assistance (TCA). This type of support mainly consists of staff permanently based in partners&#x2019; country offices. It is based on the demand and needs identified by the countries themselves.</narrative>
  </description>
  <description type="4">
   <narrative xml:lang="FR">Cette activit&#xE9; d&#xE9;taille notre travail sur le Aide cibl&#xE9;e aux pays en &#xC9;thiopie (l&apos;), gr&#xE2;ce &#xE0; la mise &#xE0; disposition des donn&#xE9;es budg&#xE9;taires et des transactions. Nous fournissons &#xE9;galement les documents pertinents qui guident ces activit&#xE9;s que sont les formulaires de demande de soutien fournis par le gouvernement de &#xC9;thiopie (l&apos;) ainsi que les lettres de d&#xE9;cisions &#xE9;mises par Gavi, pour progresser. Ces documents d&#xE9;crivent les activit&#xE9;s, les objectifs ainsi que les b&#xE9;n&#xE9;ficiaires.</narrative>
   <narrative xml:lang="EN">This activity details our work on Targeted country assistance in Ethiopia through the provision of budget and transaction data.  We also provide the relevant documents that guide these activities, which are the support request proposal(s) provided by the Government of Ethiopia, as well as the decision letter(s) issued by Gavi, for progress.  These documents describe the activities, the objectives as well as the beneficiaries.</narrative>
  </description>
  <participating-org role="4" type="70">
   <narrative xml:lang="EN">Acasus</narrative>
  </participating-org>
  <participating-org role="4">
   <narrative xml:lang="EN">CDC Foundation</narrative>
  </participating-org>
  <participating-org role="4">
   <narrative xml:lang="EN">Centers for Disease Control and Prevention</narrative>
  </participating-org>
  <participating-org ref="US-EIN-27-1414646" role="4" type="21">
   <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
  </participating-org>
  <participating-org role="4">
   <narrative xml:lang="EN">Consortium of Christian Relief and Development Association (CCRDA)</narrative>
  </participating-org>
  <participating-org ref="47122" role="1" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </participating-org>
  <participating-org ref="47122" role="3" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </participating-org>
  <participating-org role="4" type="70">
   <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
  </participating-org>
  <participating-org role="4">
   <narrative xml:lang="EN">John Snow, Inc.</narrative>
  </participating-org>
  <participating-org ref="XI-GRID-grid.21107.35" role="4">
   <narrative xml:lang="EN">Johns Hopkins University</narrative>
  </participating-org>
  <participating-org ref="US-EIN-91-1157127" role="4">
   <narrative xml:lang="EN">PATH</narrative>
  </participating-org>
  <participating-org role="4" type="10">
   <narrative xml:lang="EN">The Government of Ethiopia</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-41122" role="4" type="40">
   <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
  </participating-org>
  <participating-org ref="XI-GRID-grid.5510.1" role="4" type="80">
   <narrative xml:lang="EN">University of Oslo</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-928" role="4" type="40">
   <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
  </participating-org>
  <other-identifier ref="47122" type="B1">
   <owner-org ref="47122">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </owner-org>
  </other-identifier>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2019-01-01" type="1"></activity-date>
  <activity-date iso-date="2019-01-01" type="2"></activity-date>
  <activity-date iso-date="2023-12-31" type="3"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </organisation>
   <email>info@gavi.org</email>
   <website>http://www.gavi.org/</website>
  </contact-info>
  <activity-scope code="4"></activity-scope>
  <recipient-country code="ET" percentage="100"></recipient-country>
  <location>
   <location-reach code="1"></location-reach>
   <location-id code="ET" vocabulary="A4"></location-id>
   <name>
    <narrative xml:lang="EN">Addis Ababa</narrative>
   </name>
   <administrative code="ET" vocabulary="A4"></administrative>
   <point srsName="http://www.opengis.net/def/crs/EPSG/0/4326">
    <pos>9.02497 38.74689</pos>
   </point>
   <exactness code="2"></exactness>
   <location-class code="2"></location-class>
  </location>
  <sector code="TCA" percentage="100" vocabulary="99">
   <narrative xml:lang="EN">Targeted country assistance</narrative>
  </sector>
  <sector code="12250" percentage="100" vocabulary="1"></sector>
  <tag code="1" vocabulary="2"></tag>
  <tag code="10" vocabulary="2"></tag>
  <tag code="11" vocabulary="2"></tag>
  <tag code="13" vocabulary="2"></tag>
  <tag code="16" vocabulary="2"></tag>
  <tag code="17" vocabulary="2"></tag>
  <tag code="2" vocabulary="2"></tag>
  <tag code="3" vocabulary="2"></tag>
  <tag code="4" vocabulary="2"></tag>
  <tag code="5" vocabulary="2"></tag>
  <tag code="7" vocabulary="2"></tag>
  <tag code="8" vocabulary="2"></tag>
  <tag code="9" vocabulary="2"></tag>
  <policy-marker code="1" significance="2" vocabulary="1"></policy-marker>
  <policy-marker code="9" significance="2" vocabulary="1"></policy-marker>
  <collaboration-type code="2"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget status="2" type="2">
   <period-start iso-date="2019-01-01"></period-start>
   <period-end iso-date="2019-12-31"></period-end>
   <value currency="USD" value-date="2022-03-29">4432462</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2020-01-01"></period-start>
   <period-end iso-date="2020-12-31"></period-end>
   <value currency="USD" value-date="2022-03-29">5872395</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2021-01-01"></period-start>
   <period-end iso-date="2021-12-31"></period-end>
   <value currency="USD" value-date="2022-03-29">4906652</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-01-01"></period-start>
   <period-end iso-date="2022-12-31"></period-end>
   <value currency="USD" value-date="2022-03-29">1161687</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2023-01-01"></period-start>
   <period-end iso-date="2023-12-31"></period-end>
   <value currency="USD" value-date="2022-03-29">87979</value>
  </budget>
  <capital-spend percentage="0"></capital-spend>
  <transaction ref="ETHPEF-TCA-ACASUS2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">692704</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-CCRDA2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">424607</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-CCRDA (Consortium of Christian Relief and Development Association (CCRDA))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Consortium of Christian Relief and Development Association (CCRDA)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-CDC2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">27000</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-CDC (Centers for Disease Control and Prevention)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Centers for Disease Control and Prevention</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-CDC FOUND2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">579600</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-CHAI2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">108789</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-JHU2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">172399</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-JOHN SNOW2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">195516</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-JOHN SNOW (John Snow, Inc.)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">John Snow, Inc.</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-PATH2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">444153</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-UNI OF OSLO2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">13677</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-UNIC2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">954615</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-WHO2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">819401</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-ACASUS2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">876340</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-CCRDA2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">447910</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-CCRDA (Consortium of Christian Relief and Development Association (CCRDA))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Consortium of Christian Relief and Development Association (CCRDA)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-CDC FOUND2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">282936</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-CHAI2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">383593</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-JHU2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">0</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-JOHN SNOW2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">219190</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-JOHN SNOW (John Snow, Inc.)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">John Snow, Inc.</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-JSI2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">109500</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-PATH2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">945887</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-UNI OF OSLO2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">34190</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-UNIC2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">1243469</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-WHO2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">1329381</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-ACASUS2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">907240</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-CCRDA2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">215740</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-CCRDA (Consortium of Christian Relief and Development Association (CCRDA))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Consortium of Christian Relief and Development Association (CCRDA)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-CDC FOUND2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">397552</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-CHAI2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">365928</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-JOHN SNOW2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">203651</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-JOHN SNOW (John Snow, Inc.)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">John Snow, Inc.</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-JSI2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">218999</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-PATH2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">689744</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-UNI OF OSLO2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">50726</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-UNIC2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">953191</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-WHO2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">903882</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-ACASUS2022">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-01"></transaction-date>
   <value currency="USD" value-date="2022-01-01">0</value>
   <description>
    <narrative xml:lang="EN">2022 Operational budget for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-CDC FOUND2022">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-01"></transaction-date>
   <value currency="USD" value-date="2022-01-01">101080</value>
   <description>
    <narrative xml:lang="EN">2022 Operational budget for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-CHAI2022">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-01"></transaction-date>
   <value currency="USD" value-date="2022-01-01">68851</value>
   <description>
    <narrative xml:lang="EN">2022 Operational budget for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-JSI2022">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-01"></transaction-date>
   <value currency="USD" value-date="2022-01-01">0</value>
   <description>
    <narrative xml:lang="EN">2022 Operational budget for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-PATH2022">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-01"></transaction-date>
   <value currency="USD" value-date="2022-01-01">527480</value>
   <description>
    <narrative xml:lang="EN">2022 Operational budget for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-UNIC2022">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-01"></transaction-date>
   <value currency="USD" value-date="2022-01-01">238305</value>
   <description>
    <narrative xml:lang="EN">2022 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-WHO2022">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-01"></transaction-date>
   <value currency="USD" value-date="2022-01-01">225971</value>
   <description>
    <narrative xml:lang="EN">2022 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ETHPEF-TCA-PATH2023">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-01"></transaction-date>
   <value currency="USD" value-date="2022-01-01">87979</value>
   <description>
    <narrative xml:lang="EN">2023 Operational budget for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001020">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">133912</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001185">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-06-30"></transaction-date>
   <value currency="USD" value-date="2019-06-30">96517</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900006978">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-20"></transaction-date>
   <value currency="USD" value-date="2019-09-20">261840</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001176">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">-41782</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001176">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">41782</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001263">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">950</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000329">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-02-13"></transaction-date>
   <value currency="USD" value-date="2020-02-13">41782</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000440">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-02-19"></transaction-date>
   <value currency="USD" value-date="2020-02-19">115920</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000870">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-17"></transaction-date>
   <value currency="USD" value-date="2020-03-17">26596</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001088">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-24"></transaction-date>
   <value currency="USD" value-date="2020-03-24">115920</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002509">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-06-22"></transaction-date>
   <value currency="USD" value-date="2020-06-22">15877</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002508">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-06-22"></transaction-date>
   <value currency="USD" value-date="2020-06-22">173880</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003780">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-09-16"></transaction-date>
   <value currency="USD" value-date="2020-09-16">115920</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003820">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-09-21"></transaction-date>
   <value currency="USD" value-date="2020-09-21">4843</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">-157702</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">157702</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005199">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-08"></transaction-date>
   <value currency="USD" value-date="2020-12-08">115920</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005409">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-17"></transaction-date>
   <value currency="USD" value-date="2020-12-17">6319</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-185144</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000008">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">185144</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001335">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-29"></transaction-date>
   <value currency="USD" value-date="2021-03-29">115920</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001380">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-30"></transaction-date>
   <value currency="USD" value-date="2021-03-30">13155</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003036">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-30"></transaction-date>
   <value currency="USD" value-date="2021-06-30">173880</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003065">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-07-14"></transaction-date>
   <value currency="USD" value-date="2021-07-14">5605</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003730">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-08-10"></transaction-date>
   <value currency="USD" value-date="2021-08-10">95500</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004515">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-21"></transaction-date>
   <value currency="USD" value-date="2021-09-21">47750</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004905">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-10-05"></transaction-date>
   <value currency="USD" value-date="2021-10-05">120840</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005147">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-10-12"></transaction-date>
   <value currency="USD" value-date="2021-10-12">47750</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005318">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-10-18"></transaction-date>
   <value currency="USD" value-date="2021-10-18">66868</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100006774">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-03"></transaction-date>
   <value currency="USD" value-date="2021-12-03">120840</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100006950">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-07"></transaction-date>
   <value currency="USD" value-date="2021-12-07">500</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100006949">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-07"></transaction-date>
   <value currency="USD" value-date="2021-12-07">5431</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001016">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">244742</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CCRDA (Consortium of Christian Relief and Development Association (CCRDA))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Consortium of Christian Relief and Development Association (CCRDA)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001181">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-06-30"></transaction-date>
   <value currency="USD" value-date="2019-06-30">-27805</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CCRDA (Consortium of Christian Relief and Development Association (CCRDA))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Consortium of Christian Relief and Development Association (CCRDA)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001315">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-07-31"></transaction-date>
   <value currency="USD" value-date="2019-07-31">-163303</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CCRDA (Consortium of Christian Relief and Development Association (CCRDA))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Consortium of Christian Relief and Development Association (CCRDA)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900003836">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-08-31"></transaction-date>
   <value currency="USD" value-date="2019-08-31">126672</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CCRDA (Consortium of Christian Relief and Development Association (CCRDA))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Consortium of Christian Relief and Development Association (CCRDA)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001252">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">33715</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CCRDA (Consortium of Christian Relief and Development Association (CCRDA))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Consortium of Christian Relief and Development Association (CCRDA)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700000432">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">-33715</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CCRDA (Consortium of Christian Relief and Development Association (CCRDA))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Consortium of Christian Relief and Development Association (CCRDA)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000340">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-02-17"></transaction-date>
   <value currency="USD" value-date="2020-02-17">210586</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CCRDA (Consortium of Christian Relief and Development Association (CCRDA))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Consortium of Christian Relief and Development Association (CCRDA)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003100">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-08-31"></transaction-date>
   <value currency="USD" value-date="2020-08-31">27416</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CCRDA (Consortium of Christian Relief and Development Association (CCRDA))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Consortium of Christian Relief and Development Association (CCRDA)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">-210586</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CCRDA (Consortium of Christian Relief and Development Association (CCRDA))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Consortium of Christian Relief and Development Association (CCRDA)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">210586</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CCRDA (Consortium of Christian Relief and Development Association (CCRDA))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Consortium of Christian Relief and Development Association (CCRDA)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-46283</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CCRDA (Consortium of Christian Relief and Development Association (CCRDA))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Consortium of Christian Relief and Development Association (CCRDA)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000008">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">46283</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CCRDA (Consortium of Christian Relief and Development Association (CCRDA))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Consortium of Christian Relief and Development Association (CCRDA)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000296">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-01-28"></transaction-date>
   <value currency="USD" value-date="2021-01-28">43607</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CCRDA (Consortium of Christian Relief and Development Association (CCRDA))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Consortium of Christian Relief and Development Association (CCRDA)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001469">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-22"></transaction-date>
   <value currency="USD" value-date="2021-03-22">-2990</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CCRDA (Consortium of Christian Relief and Development Association (CCRDA))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Consortium of Christian Relief and Development Association (CCRDA)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001469">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-22"></transaction-date>
   <value currency="USD" value-date="2021-03-22">2990</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CCRDA (Consortium of Christian Relief and Development Association (CCRDA))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Consortium of Christian Relief and Development Association (CCRDA)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001179">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-23"></transaction-date>
   <value currency="USD" value-date="2021-03-23">65951</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CCRDA (Consortium of Christian Relief and Development Association (CCRDA))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Consortium of Christian Relief and Development Association (CCRDA)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002763">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-16"></transaction-date>
   <value currency="USD" value-date="2021-06-16">68001</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CCRDA (Consortium of Christian Relief and Development Association (CCRDA))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Consortium of Christian Relief and Development Association (CCRDA)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003333">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-07-15"></transaction-date>
   <value currency="USD" value-date="2021-07-15">32243</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CCRDA (Consortium of Christian Relief and Development Association (CCRDA))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Consortium of Christian Relief and Development Association (CCRDA)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004977">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-11-15"></transaction-date>
   <value currency="USD" value-date="2021-11-15">43597</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CCRDA (Consortium of Christian Relief and Development Association (CCRDA))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Consortium of Christian Relief and Development Association (CCRDA)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100006867">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-15"></transaction-date>
   <value currency="USD" value-date="2021-12-15">131064</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CCRDA (Consortium of Christian Relief and Development Association (CCRDA))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Consortium of Christian Relief and Development Association (CCRDA)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700006617">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">-3293</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CCRDA (Consortium of Christian Relief and Development Association (CCRDA))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Consortium of Christian Relief and Development Association (CCRDA)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700006617">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">3293</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CCRDA (Consortium of Christian Relief and Development Association (CCRDA))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Consortium of Christian Relief and Development Association (CCRDA)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001955">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2022-03-10"></transaction-date>
   <value currency="USD" value-date="2022-03-10">3992</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CCRDA (Consortium of Christian Relief and Development Association (CCRDA))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Consortium of Christian Relief and Development Association (CCRDA)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001955">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2022-03-10"></transaction-date>
   <value currency="USD" value-date="2022-03-10">6283</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CCRDA (Consortium of Christian Relief and Development Association (CCRDA))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Consortium of Christian Relief and Development Association (CCRDA)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000901">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">20250</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC (Centers for Disease Control and Prevention)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Centers for Disease Control and Prevention</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000748">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-03"></transaction-date>
   <value currency="USD" value-date="2019-12-03">6750</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC (Centers for Disease Control and Prevention)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Centers for Disease Control and Prevention</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000902">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">434700</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000675">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-02"></transaction-date>
   <value currency="USD" value-date="2019-12-02">144900</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001735">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-29"></transaction-date>
   <value currency="USD" value-date="2020-04-29">282936</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001204">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-23"></transaction-date>
   <value currency="USD" value-date="2021-03-23">94312</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002631">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-08"></transaction-date>
   <value currency="USD" value-date="2021-06-08">303240</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000982">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">-2900</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001142">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-06-30"></transaction-date>
   <value currency="USD" value-date="2019-06-30">71661</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001286">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-07-31"></transaction-date>
   <value currency="USD" value-date="2019-07-31">-40028</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000849">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-12"></transaction-date>
   <value currency="USD" value-date="2019-12-12">49950</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000974">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-17"></transaction-date>
   <value currency="USD" value-date="2019-12-17">30105</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003534">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-08-31"></transaction-date>
   <value currency="USD" value-date="2020-08-31">22380</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005050">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-07"></transaction-date>
   <value currency="USD" value-date="2020-12-07">45254</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005608">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-16"></transaction-date>
   <value currency="USD" value-date="2020-12-16">9699</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-17725</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000008">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">17725</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000584">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-02-11"></transaction-date>
   <value currency="USD" value-date="2021-02-11">67140</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001232">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-25"></transaction-date>
   <value currency="USD" value-date="2021-03-25">22811</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001906">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-04-30"></transaction-date>
   <value currency="USD" value-date="2021-04-30">45623</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003278">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-07-13"></transaction-date>
   <value currency="USD" value-date="2021-07-13">521</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002484">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-30"></transaction-date>
   <value currency="USD" value-date="2021-09-30">61613</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005328">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-10-20"></transaction-date>
   <value currency="USD" value-date="2021-10-20">110774</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001017">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">233032</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.21107.35">
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001182">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-06-30"></transaction-date>
   <value currency="USD" value-date="2019-06-30">-65027</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.21107.35">
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001316">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-07-31"></transaction-date>
   <value currency="USD" value-date="2019-07-31">-65027</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.21107.35">
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900006979">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-20"></transaction-date>
   <value currency="USD" value-date="2019-09-20">69421</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.21107.35">
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001018">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">50562</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JOHN SNOW (John Snow, Inc.)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">John Snow, Inc.</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001183">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-06-30"></transaction-date>
   <value currency="USD" value-date="2019-06-30">71757</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JOHN SNOW (John Snow, Inc.)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">John Snow, Inc.</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001317">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-07-31"></transaction-date>
   <value currency="USD" value-date="2019-07-31">-117397</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JOHN SNOW (John Snow, Inc.)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">John Snow, Inc.</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900003837">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-08-31"></transaction-date>
   <value currency="USD" value-date="2019-08-31">81085</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JOHN SNOW (John Snow, Inc.)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">John Snow, Inc.</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001199">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">-14315</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JOHN SNOW (John Snow, Inc.)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">John Snow, Inc.</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001199">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">14315</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JOHN SNOW (John Snow, Inc.)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">John Snow, Inc.</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001252">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">80877</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JOHN SNOW (John Snow, Inc.)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">John Snow, Inc.</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700000432">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">-80877</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JOHN SNOW (John Snow, Inc.)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">John Snow, Inc.</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000221">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-02-04"></transaction-date>
   <value currency="USD" value-date="2020-02-04">14315</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JOHN SNOW (John Snow, Inc.)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">John Snow, Inc.</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000923">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-17"></transaction-date>
   <value currency="USD" value-date="2020-03-17">20501</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JOHN SNOW (John Snow, Inc.)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">John Snow, Inc.</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002771">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-07-06"></transaction-date>
   <value currency="USD" value-date="2020-07-06">47885</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JOHN SNOW (John Snow, Inc.)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">John Snow, Inc.</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004759">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-11-24"></transaction-date>
   <value currency="USD" value-date="2020-11-24">28030</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JOHN SNOW (John Snow, Inc.)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">John Snow, Inc.</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">-14315</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JOHN SNOW (John Snow, Inc.)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">John Snow, Inc.</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">14315</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JOHN SNOW (John Snow, Inc.)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">John Snow, Inc.</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-15461</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JOHN SNOW (John Snow, Inc.)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">John Snow, Inc.</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-18677</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JOHN SNOW (John Snow, Inc.)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">John Snow, Inc.</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-3397</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JOHN SNOW (John Snow, Inc.)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">John Snow, Inc.</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000008">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">15461</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JOHN SNOW (John Snow, Inc.)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">John Snow, Inc.</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000008">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">18677</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JOHN SNOW (John Snow, Inc.)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">John Snow, Inc.</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000008">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">3397</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JOHN SNOW (John Snow, Inc.)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">John Snow, Inc.</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000769">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-02-25"></transaction-date>
   <value currency="USD" value-date="2021-02-25">28030</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JOHN SNOW (John Snow, Inc.)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">John Snow, Inc.</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001942">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-04-30"></transaction-date>
   <value currency="USD" value-date="2021-04-30">162</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JOHN SNOW (John Snow, Inc.)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">John Snow, Inc.</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002013">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-08"></transaction-date>
   <value currency="USD" value-date="2021-06-08">62072</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JOHN SNOW (John Snow, Inc.)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">John Snow, Inc.</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003822">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-08-12"></transaction-date>
   <value currency="USD" value-date="2021-08-12">47152</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JOHN SNOW (John Snow, Inc.)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">John Snow, Inc.</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005171">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-10-12"></transaction-date>
   <value currency="USD" value-date="2021-10-12">28030</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JOHN SNOW (John Snow, Inc.)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">John Snow, Inc.</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100006815">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-06"></transaction-date>
   <value currency="USD" value-date="2021-12-06">2861</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JOHN SNOW (John Snow, Inc.)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">John Snow, Inc.</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000692">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-02-18"></transaction-date>
   <value currency="USD" value-date="2021-02-18">45896</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000693">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-02-18"></transaction-date>
   <value currency="USD" value-date="2021-02-18">45896</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003498">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-07-27"></transaction-date>
   <value currency="USD" value-date="2021-07-27">46119</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100006746">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-15"></transaction-date>
   <value currency="USD" value-date="2021-12-15">71718</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000531">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2022-01-26"></transaction-date>
   <value currency="USD" value-date="2022-01-26">5504</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001019">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">-93078</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001184">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-06-30"></transaction-date>
   <value currency="USD" value-date="2019-06-30">172936</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001318">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-07-31"></transaction-date>
   <value currency="USD" value-date="2019-07-31">-172936</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900006980">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-20"></transaction-date>
   <value currency="USD" value-date="2019-09-20">290592</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700000318">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-11-19"></transaction-date>
   <value currency="USD" value-date="2019-11-19">86537</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001263">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">130102</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001252">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">30000</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700000432">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">-30000</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000977">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-19"></transaction-date>
   <value currency="USD" value-date="2020-03-19">18145</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001178">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-05-14"></transaction-date>
   <value currency="USD" value-date="2020-05-14">60877</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002723">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-07-06"></transaction-date>
   <value currency="USD" value-date="2020-07-06">148072</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002734">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-07-06"></transaction-date>
   <value currency="USD" value-date="2020-07-06">99181</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-43349</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000008">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">43349</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000311">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-02-02"></transaction-date>
   <value currency="USD" value-date="2021-02-02">103828</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000700">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-02-18"></transaction-date>
   <value currency="USD" value-date="2021-02-18">143756</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000163">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-02-18"></transaction-date>
   <value currency="USD" value-date="2021-02-18">30178</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001469">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-22"></transaction-date>
   <value currency="USD" value-date="2021-03-22">-86428</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001469">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-22"></transaction-date>
   <value currency="USD" value-date="2021-03-22">86428</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001523">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-04-26"></transaction-date>
   <value currency="USD" value-date="2021-04-26">51458</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003010">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-30"></transaction-date>
   <value currency="USD" value-date="2021-06-30">103366</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003108">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-30"></transaction-date>
   <value currency="USD" value-date="2021-06-30">59762</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003010">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-30"></transaction-date>
   <value currency="USD" value-date="2021-06-30">74060</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700006617">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">-74060</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700006617">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">74060</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001957">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2022-03-10"></transaction-date>
   <value currency="USD" value-date="2022-03-10">175414</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700000318">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-11-19"></transaction-date>
   <value currency="USD" value-date="2019-11-19">12101</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001283">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">-816</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000949">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-18"></transaction-date>
   <value currency="USD" value-date="2020-03-18">16190</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004212">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-11-10"></transaction-date>
   <value currency="USD" value-date="2020-11-10">2374</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-14726</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000007">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">14726</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004265">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-07"></transaction-date>
   <value currency="USD" value-date="2021-09-07">1800</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004623">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-23"></transaction-date>
   <value currency="USD" value-date="2021-09-23">4200</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004623">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-23"></transaction-date>
   <value currency="USD" value-date="2021-09-23">900</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000903">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">715961</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000229">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-02-04"></transaction-date>
   <value currency="USD" value-date="2020-02-04">238654</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001481">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-14"></transaction-date>
   <value currency="USD" value-date="2020-04-14">714827</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">-238654</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">238654</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005692">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-21"></transaction-date>
   <value currency="USD" value-date="2020-12-21">289767</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001377">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-30"></transaction-date>
   <value currency="USD" value-date="2021-03-30">238276</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004024">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-08-26"></transaction-date>
   <value currency="USD" value-date="2021-08-26">714916</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000904">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">702344</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000231">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-02-04"></transaction-date>
   <value currency="USD" value-date="2020-02-04">117057</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001657">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-28"></transaction-date>
   <value currency="USD" value-date="2020-04-28">677910</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">-117057</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">117057</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005691">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-21"></transaction-date>
   <value currency="USD" value-date="2020-12-21">534413</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004708">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-28"></transaction-date>
   <value currency="USD" value-date="2021-09-28">677912</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/role-expanded-partners-under-pef-guidance-note">
   <title>
    <narrative xml:lang="EN">Partners&#x2019; engagement framework</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Guidance on the role of expanded partners in the provision of targeted country assistance</narrative>
   </description>
   <category code="A04"></category>
   <language code="EN"></language>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/directives-concernant-le-processus-mis-en-place-au-titre-de-laide">
   <title>
    <narrative xml:lang="EN">Directives concernant le processus mis en place au titre de l&#x2019;aide cibl&#xE9;e aux pays dans le cadre du PEF</narrative>
   </title>
   <category code="A04"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-ethiopia-2017">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Ethiopia 2017</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2017-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-ethiopia-2017">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Ethiopia 2017</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2017-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-ethiopia-2018">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Ethiopia 2018</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2018-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-ethiopia-2018">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Ethiopia 2018</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2018-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-ethiopia-2019">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Ethiopia 2019</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2019-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-ethiopia-2019">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Ethiopia 2019</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2019-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-ethiopia-2020">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Ethiopia 2020</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2020-07-13"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-ethiopia-2021">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Ethiopia 2021</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2021-07-27"></document-date>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/types-support/pef/targeted-country-assistance">
   <title>
    <narrative xml:lang="EN">About targeted country assistance</narrative>
   </title>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/fr/types-de-soutien/pef/aide-ciblee-aux-pays">
   <title>
    <narrative xml:lang="EN">&#xC0; propos de l&#x2019;aide cibl&#xE9;e aux pays</narrative>
   </title>
   <category code="A12"></category>
   <language code="FR"></language>
  </document-link>
  <related-activity ref="47122-ETH" type="1"></related-activity>
  <conditions attached="1">
   <condition type="2">
    <narrative xml:lang="EN">Conditions are detailed in the Partners&#x2019; engagement framework</narrative>
    <narrative xml:lang="FR">Conditions are detailed in the Partners&#x2019; engagement framework</narrative>
   </condition>
  </conditions>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Programme Management - General</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Implementations of policy/cMYP</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1.Organize consultative workshop and write up meetings to discuss on and revise the current EPI policy,  implementation guide and cMYP development and write up meetings to revise/update the national IIP training modules">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1.Organize consultative workshop and write up meetings to discuss on and revise the current EPI policy,  implementation guide and cMYP development and write up meetings to revise/update the national IIP training modules">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">PATH : Demand Promotion &amp; ACSM</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Participated in national communication working group</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Assist in the planning, implementation and monitoring of national communication plan with participation in national CWG">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Assist in the planning, implementation and monitoring of national communication plan with participation in national CWG">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Participated in regional communication working group</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Assist in the planning, implementation and monitoring of regional communication plan with participation in regional CWG">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Assist in the planning, implementation and monitoring of regional communication plan with participation in regional CWG">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Orientation workshop for public relation officers and media professionals provided in Afar and Somali regions</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Organize orientation workshop on immunization for public relation officers and media professionals in Afar and Somali regions  
- Identify local media professionals and public relation officers 
- Prepare training materials  
- Provide orientation for identified participants">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Organize orientation workshop on immunization for public relation officers and media professionals in Afar and Somali regions  
- Identify local media professionals and public relation officers 
- Prepare training materials  
- Provide orientation for identified participants">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. IPC training provided for 80 participants from 8 project woreds</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide interpersonal communication (IPC) training for healthcare providers from 8 project woredas of Afar and Somali regions  
- Developed tailored training materials  
- Provided IPC training for vaccinators  
- Evaluated impact of the training">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide interpersonal communication (IPC) training for healthcare providers from 8 project woredas of Afar and Somali regions  
- Developed tailored training materials  
- Provided IPC training for vaccinators  
- Evaluated impact of the training">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">IPC training materials developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide interpersonal communication (IPC) training for healthcare providers from 8 project woredas of Afar and Somali regions - Developed tailored training materials - Provided IPC training for vaccinators - Evaluated impact of the training - Develop comprehensive EPI checklist together with regional and woreda EPI team - Conduct supportive supervision using checklist - Provide onsite and written feedback - Identify and register unreached children under 2 years of age and pregnant women and register - Support PIRI implementation to vaccinate identified targets - Support monitoring of PIRI implementation status - Provide orientation on RED approach, PIRI strategy and RED micro-plan development processes - Support development of RED microplanning - Support monitoring of RED micro-plan utilization - Support revision of RED micro-plan">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">2. Softcopy of translated materials provided to RHBs, woreda health offices and health facilities</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support translation of IPC materials - Translate national IPC material in to Afar and Somali languages - Provide softcopy of translated materials to RHBs, Woreda health offices and health facilities">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Regional level advocacy organized in Afar and Somali regions</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Organize higher level regional advocacy on immunization for Afar and Somali regions">
      <location ref="ET"></location>
     </target>
     <actual value="Major Delays">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Organize higher level regional advocacy on immunization for Afar and Somali regions">
      <location ref="ET"></location>
     </target>
     <actual value="Major Delays">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Organize higher level regional advocacy on immunization for Afar and Somali regions">
      <location ref="ET"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Supported the planning and organization of 2021 AVW</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support 2021 AVW planning and implementation">
      <location ref="ET"></location>
     </target>
     <actual value="Major Delays">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support 2021 AVW planning and implementation">
      <location ref="ET"></location>
     </target>
     <actual value="Major Delays">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support 2021 AVW planning and implementation">
      <location ref="ET"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">2. IPC training impact evaluated in 4 project woredas (2 from each region)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide interpersonal communication (IPC) training for healthcare providers from 8 project woredas of Afar and Somali regions - Developed tailored training materials - Provided IPC training for vaccinators - Evaluated impact of the training">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide interpersonal communication (IPC) training for healthcare providers from 8 project woredas of Afar and Somali regions  
- Developed tailored training materials  
- Provided IPC training for vaccinators  
- Evaluated impact of the training">
      <location ref="ET"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide interpersonal communication (IPC) training for healthcare providers from 8 project woredas of Afar and Somali regions  
- Developed tailored training materials  
- Provided IPC training for vaccinators  
- Evaluated impact of the training">
      <location ref="ET"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Data</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Data desk review or triangulation analysis performed (coverage, surveillance, operational, others)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct data triangulation workshop to estimate national and subnational immunization coverage estimates using global data triangulation guideline(s)">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct data triangulation workshop to estimate national and subnational immunization coverage estimates using global data triangulation guideline(s)">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct data triangulation workshop to estimate national and subnational immunization coverage estimates using global data triangulation guideline(s)">
      <location ref="ET"></location>
     </target>
     <actual value="Major Delays">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Data Improvement Plan (DIP) developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct joint quarterly visits to regions to evaluate data validation and data triangulation systems focusing in the four big region">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Training on RDQA/DQS methodology for national and regional experts (30-40)">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Training on RDQA/DQS methodology for national and regional experts (30-40)">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Training on RDQA/DQS methodology for national and regional experts (30-40)">
      <location ref="ET"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Training on RDQA/DQS methodology for national and regional experts (30-40)">
      <location ref="ET"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Data Improvement Plan (DIP) implemented</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Training on RDQA/DQS methodology for national and regional experts (30-40)">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Training on RDQA/DQS methodology for national and regional experts (30-40)">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">In-depth assessment of data quality (DQR, DQA, audit) performed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct joint quarterly visits to regions to evaluate data validation and data triangulation systems focusing in the four big region">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct joint quarterly visits to regions to evaluate data validation and data triangulation systems focusing in the four big region">
      <location ref="ET"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">PATH : Health Information Systems (Data)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Participated in national M&amp;E technical working group</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Assist in the planning, implementation and monitoring of national data quality improvement plan, program quality with participation in national M and E WG">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Assist in the planning, implementation and monitoring of national data quality improvement plan, program quality with participation in national M and E WG">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Participated in regional M&amp;E technical working group</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Assist in the planning, implementation and monitoring of regional data quality improvement plan, program quality with participation in regional M and E WG">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Assist in the planning, implementation and monitoring of regional data quality improvement plan, program quality with participation in regional M and E WG">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">DQS conducted in all project woredas</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct Data Quality Self-assessment (DQS) in 8 project woredas of Afar and Somali regions">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct Data Quality Self-assessment (DQS) in 8 project woredas of Afar and Somali regions">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Capacity built</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct training on COVID prevention mechanisms, on mainitaining RI during the pandemic">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. One round onsite mentoring provided for Afar and Somali RHBs and 8 project woreda health offices</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support Afar and Somali RHBs and 8 project woredas EPI team to utilize DHIS2 for program monitoring 
- Provide onsite mentoring for Afar and Somali RHB and 8 project woreda health office EPI team on DHIS2 features   
-  Assist Afar and Somali RHB and 8 project woreda health office EPI team to design EPI specific dashboards  
- Assist Afar and Somali RHB and 8 project woreda health office EPI team to monitor EPI using DHIS2">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support Afar and Somali RHBs and 8 project woredas EPI team to utilize DHIS2 for program monitoring 
- Provide onsite mentoring for Afar and Somali RHB and 8 project woreda health office EPI team on DHIS2 features   
-  Assist Afar and Somali RHB and 8 project woreda health office EPI team to design EPI specific dashboards  
- Assist Afar and Somali RHB and 8 project woreda health office EPI team to monitor EPI using DHIS2">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">2. Afar and Somali RHBs and 8 project woreda health office EPI team assisted in designing EPI specific dashboard</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support Afar and Somali RHBs and 8 project woredas EPI team to utilize DHIS2 for program monitoring 
- Provide onsite mentoring for Afar and Somali RHB and 8 project woreda health office EPI team on DHIS2 features   
-  Assist Afar and Somali RHB and 8 project woreda health office EPI team to design EPI specific dashboards  
- Assist Afar and Somali RHB and 8 project woreda health office EPI team to monitor EPI using DHIS2">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support Afar and Somali RHBs and 8 project woredas EPI team to utilize DHIS2 for program monitoring 
- Provide onsite mentoring for Afar and Somali RHB and 8 project woreda health office EPI team on DHIS2 features   
-  Assist Afar and Somali RHB and 8 project woreda health office EPI team to design EPI specific dashboards  
- Assist Afar and Somali RHB and 8 project woreda health office EPI team to monitor EPI using DHIS2">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Risk communication strategy developed and implemented</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support for risk communication strategy cascade">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Annual EPI program review meeting conducted in Afar and Somali regions</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct regional data driven annual EPI program review in Afar and Somali regions">
      <location ref="ET"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct regional data driven annual EPI program review in Afar and Somali regions">
      <location ref="ET"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct regional data driven annual EPI program review in Afar and Somali regions">
      <location ref="ET"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Post covid 19 strategy developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Developing action plans for covid exit strategy">
      <location ref="ET"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Service Delivery</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Data desk review or triangulation analysis performed (coverage, surveillance, operational, others)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Coverage survey conducted  in at least 70 villages far from health facilities and risk communities in 14 zones to generate evidence on zero dose and under vaccination">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Routine immunisation coverage survey (national /targeted - various methods) implemented</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Coverage survey conducted  in at least 70 villages far from health facilities and risk communities in 14 zones to generate evidence on zero dose and under vaccination">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Data improvement field activity implemented (review, validation, monitoring, harmonisation, mentorship, workshop, others)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Identification , mapping, and targeting through REC micro-plan preparation to reach  missed/underserved communities in six zones with high number of zero dose children">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Data Improvement Plan (DIP) implemented</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Immunization service avilability monitored  biannually by type of HFs in 14 Zones  and at least one advocacy meeting conducted per zone for service expantion">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Master facility list platform implemented</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Immunization service avilability monitored  biannually by type of HFs in 14 Zones  and at least one advocacy meeting conducted per zone for service expantion">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Equity or Accessibility assessment performed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Identification , mapping, and targeting through REC micro-plan preparation to reach  missed/underserved communities in six zones with high number of zero dose children">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">John Snow, Inc. : Supply Chain &amp; Procurement</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">All live sites have system with new features</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Add new features to mBrana to comply with TSS">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Add new features to mBrana to comply with TSS">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">75 new sites with live data visibility, and ordering electronically</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Deploy new system to 75 new sites.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Deploy new system to 75 new sites.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Two Regional community engagement strategies for high risk communties available for SNNP and Oromia</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Enhance community engagement in the UNICEF supported 14 zones of three large regions and Addis Ababa to increase immunization uptake Key activities 1 Develop and implement tailored behavior and social changes strategy for remote rural, urban scattered communities , conflict affected and communities with low socio-economic status and implementation in 14 zones in Amhara Oromia and SNNPR 2. Monitoring of community participation, especially of women, in the planning and monitoring of immunization sessions in the framework of the RED/REC 3. Strengthen SBCC coordination at regional level and in 14 UNICEF targeted zones, among programmes, particularly of EPI and HEP, and partners including women networks and other local CSOs; 4. Support MCV2 , Measles SIA and NVI roll out in communication planning, development/adjustment of communication tools, and monitoring">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">Clinton Health Access Initiative : Vaccine-Specific Support</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">quarterly SS and Mentoring to selected Private HFs conducted</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct continuous supportive supervision, monitoring and evaluation">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct continuous supportive supervision, monitoring and evaluation">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Regular SS and Mentoring to selected Private HFs conducted</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct continuous supportive supervision, monitoring and evaluation">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Readiness assessment for HPV Implementation for 2nd cohort implementation conducted, recommendations for mitigating any bottlenecks or challenges made</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conducted preliminary supportive supervision and report the findings to the FMOH on different preparatory activities of the HPV and other NVI introduction, including support to any necessary analysis of data">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conducted preliminary supportive supervision and report the findings to the FMOH on different preparatory activities of the HPV and other NVI introduction, including support to any necessary analysis of data">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Detailed HPV Micro plan developed and utilised for new HPV cohort administration</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Develop detailed HPV Vaccine introduction plan/micro-plan with timelines and clear responsibilities">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Develop detailed HPV Vaccine introduction plan/micro-plan with timelines and clear responsibilities">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Experience sharing and sensitisation workshop conducted</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Experience sharing with government health facilities with long time experience of RI service delivery will also be conducted.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Experience sharing with government health facilities with long time experience of RI service delivery will also be conducted.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Strengthened coordination contributed to timely HPV implementation as per plan</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Facilitate partners and different technical working group meetings in preparation and timely distribution of training manuals, guidelines, job-aids, and communication tools on HPV">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Facilitate partners and different technical working group meetings in preparation and timely distribution of training manuals, guidelines, job-aids, and communication tools on HPV">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Identified bottlenecks and gaps in RI service delivery by private health facilities. Based on bottleneck assessment action plan developed and shared with MOH</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Identify bottlenecks and gaps in RI service delivery by private health facilities and based on the need assessment provide mitigating annual plan to improve the quality of the service being provided.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Identify bottlenecks and gaps in RI service delivery by private health facilities and based on the need assessment provide mitigating annual plan to improve the quality of the service being provided.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Subnational MP developed and utilised</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Organize sub-national microplanning ?exercise and collect and compile MPs at the central level">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Organize sub-national microplanning ?exercise and collect and compile MPs at the central level">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Technical Support provided for MoH on NVI at all levels</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide all rounded TA to other NVIs in pipeline">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide all rounded TA to other NVIs in pipeline">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Mitigations identified are implemented on a timely manner for H2 2021 vaccination cohort, with sustainability plans defined</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Review and analyze monitoring and implementation data to identify challenges and take corrective actions">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Review and analyze monitoring and implementation data to identify challenges and take corrective actions">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">?All preparation, implementation and monitoring of the NVI/HPV activities implemented as per the chronogram developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support EPI taskforce and technical working groups (EPI Logistics, Communication and monitoring and evaluation) in planning adequate Cold Chain and Supply, developing appropriate communication materials and monitoring of the planned activities implementation">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support EPI taskforce and technical working groups (EPI Logistics, Communication and monitoring and evaluation) in planning adequate Cold Chain and Supply, developing appropriate communication materials and monitoring of the planned activities implementation">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">50 Private HFs EPI Focal/Vaccinators trained on standard IIP and EVMA training</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support capacity building activities by providing the required training such as Vaccine management, IIP, MLM, preventive maintenance, including on job training.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support capacity building activities by providing the required training such as Vaccine management, IIP, MLM, preventive maintenance, including on job training.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Recommendations shared and action plan developed with FMOH for optimizing RI service at private HFs</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support coordination of optimisation of the necessary service delivery components in private health facilities (such as make sure they are using optimal cold chain equipment, temperature monitoring devices, injection safety measures, proper recording and reporting system, effective vaccine management etc.).">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support coordination of optimisation of the necessary service delivery components in private health facilities (such as make sure they are using optimal cold chain equipment, temperature monitoring devices, injection safety measures, proper recording and reporting system, effective vaccine management etc.).">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Any bottlenecks w/ novel routine RI data reporting system identified, and mitigation recommendations developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support establishment of routine reporting system">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support establishment of routine reporting system">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">?HPV implementation regularly monitored?and reviewed, and actions taken</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the FMOH to implement coordinated and cascaded post introduction monitoring activities such as supportive supervisions, review meetings, regular reporting of the HPV immunisation status">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the FMOH to implement coordinated and cascaded post introduction monitoring activities such as supportive supervisions, review meetings, regular reporting of the HPV immunisation status">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">NVI decision making best practices and Lessons learned identified and documented for subsequent reviews</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the documentation of lessons learnt to be shared as best practices from the introduction of new vaccine">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the documentation of lessons learnt to be shared as best practices from the introduction of new vaccine">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Regular Support to AARHB provided</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support to Addis Ababa regional Health Bureau in strengthening optimizing, monitoring and capacity building activities to private routine immunisation delivering health facilities">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support to Addis Ababa regional Health Bureau in strengthening optimizing, monitoring and capacity building activities to private routine immunisation delivering health facilities">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Annual Review meeting conducted, challenges identified, and action plan developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Facilitate review meeting to evaluate the outcomes as per the plan and document the lesson learnt and share.">
      <location ref="ET"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Facilitate review meeting to evaluate the outcomes as per the plan and document the lesson learnt and share.">
      <location ref="ET"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Facilitate review meeting to evaluate the outcomes as per the plan and document the lesson learnt and share.">
      <location ref="ET"></location>
     </target>
     <actual>
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Global PIE recommendations integrated into H2 2021 activities for subsequent cohorts?</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Mitigations identified are implemented on a timely manner for H2 2021 vaccination cohort, with sustainability plans defined">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Mitigations identified are implemented on a timely manner for H2 2021 vaccination cohort, with sustainability plans defined">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Guideline developed and validated by MOH</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support Guideline development for engaging private facilities in EPI services">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support Guideline development for engaging private facilities in EPI services">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">CDC Foundation : Programme Implementation/Coverage &amp; Equity</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Funding received, a) IRB protocol developed and submitted for review; b-e) reference materials gathered, best practices materials gathered from other countries, and locally to strengthen implementation; f) continue work started last TCA cycle</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In support the introduction of MCV2 in Ethiopia in early 2019, technical support subnationally in one large Region (specificially Oromia Region), including a) operations research to identify and mitigate barriers to uptake of MCV2 and second year of life (2YL) services; b) support around recording/reporting of vaccines doses delivered in 2YL; c) roll-out of training materials for MCV2, with emphasis on use of MCV2 as an opportunity to catch-up children on measles vaccinations that were missed during the first year of life; d) communications messaging to increase awareness and demand for MCV2; e) capacity building for data quality assurance, analysis and triangulation for MCV1 &amp; MCV2 at the local level (i.e. health facility level within Oromia); f) experience sharnig activities on 2YL programs">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">a) Start planning for barriers study, b, c, e) report status; draft materials developed for catch-up vaccination in line with MCV2 introduction; d) assessment of impact of current messaging</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In support the introduction of MCV2 in Ethiopia in early 2019, technical support subnationally in one large Region (specificially Oromia Region), including a) operations research to identify and mitigate barriers to uptake of MCV2 and second year of life (2YL) services; b) support around recording/reporting of vaccines doses delivered in 2YL; c) roll-out of training materials for MCV2, with emphasis on use of MCV2 as an opportunity to catch-up children on measles vaccinations that were missed during the first year of life; d) communications messaging to increase awareness and demand for MCV2; e) capacity building for data quality assurance, analysis and triangulation for MCV1 &amp; MCV2 at the local level (i.e. health facility level within Oromia); f) experience sharnig activities on 2YL programs">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">a) Final report on study findings and dissemination through various fourms; b, c, e) Materials pilot tested and status reported; d) recommendations on approaches aimed at increasing awareness and demand for MCV2, with focus subnationally in Oromia Region</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In support the introduction of MCV2 in Ethiopia in early 2019, technical support subnationally in one large Region (specificially Oromia Region), including a) operations research to identify and mitigate barriers to uptake of MCV2 and second year of life (2YL) services; b) support around recording/reporting of vaccines doses delivered in 2YL; c) roll-out of training materials for MCV2, with emphasis on use of MCV2 as an opportunity to catch-up children on measles vaccinations that were missed during the first year of life; d) communications messaging to increase awareness and demand for MCV2; e) capacity building for data quality assurance, analysis and triangulation for MCV1 &amp; MCV2 at the local level (i.e. health facility level within Oromia); f) experience sharnig activities on 2YL programs">
      <location ref="ET"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In support the introduction of MCV2 in Ethiopia in early 2019, technical support subnationally in one large Region (specificially Oromia Region), including a) operations research to identify and mitigate barriers to uptake of MCV2 and second year of life (2YL) services; b) support around recording/reporting of vaccines doses delivered in 2YL; c) roll-out of training materials for MCV2, with emphasis on use of MCV2 as an opportunity to catch-up children on measles vaccinations that were missed during the first year of life; d) communications messaging to increase awareness and demand for MCV2; e) capacity building for data quality assurance, analysis and triangulation for MCV1 &amp; MCV2 at the local level (i.e. health facility level within Oromia); f) experience sharnig activities on 2YL programs">
      <location ref="ET"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In support the introduction of MCV2 in Ethiopia in early 2019, technical support subnationally in one large Region (specificially Oromia Region), including a) operations research to identify and mitigate barriers to uptake of MCV2 and second year of life (2YL) services; b) support around recording/reporting of vaccines doses delivered in 2YL; c) roll-out of training materials for MCV2, with emphasis on use of MCV2 as an opportunity to catch-up children on measles vaccinations that were missed during the first year of life; d) communications messaging to increase awareness and demand for MCV2; e) capacity building for data quality assurance, analysis and triangulation for MCV1 &amp; MCV2 at the local level (i.e. health facility level within Oromia); f) experience sharnig activities on 2YL programs">
      <location ref="ET"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">CDC Foundation : Programme Management - General</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Final report on study findings; Materials pilot tested and status reported; recommendations on approaches aimed at increasing awareness and demand for MCV2</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In support the planned introduction of MCV2 in Ethiopia in 2018, operations research to identify and mitigate barriers to uptake of second year of life (2YL) services (e.g. MCV2), and recording/reporting of vaccines doses delivered in 2YL; development and roll-out of training materials for 2YL, with emphasis on use of MCV2 as an opportunity to catch-up children on vaccinations that were missed during the first year of life; communications messaging to increase awareness and demand for MCV2">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Initiate study, and report status; draft materials developed for catch-up vaccination in line with MCV2 introduction; assessment of impact of current messaging</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In support the planned introduction of MCV2 in Ethiopia in 2018, operations research to identify and mitigate barriers to uptake of second year of life (2YL) services (e.g. MCV2), and recording/reporting of vaccines doses delivered in 2YL; development and">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Training conducted; 16 month implementation phase initiated in selected zones</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Missed opportunities for vaccination due to healthcare worker reluctance to open a multi-dose vial is well described int he literature. CDC has been working with Ethiopia MoH and WHO to design and implement a randomized control study to document and measu">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Continuation of implementation period, and reporting on status</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Missed opportunities for vaccination due to healthcare worker reluctance to open a multi-dose vial is well described int he literature. CDC has been working with Ethiopia MoH and WHO to design and implement a randomized control study to document and measure the impact of reduce Measles vial size from 10 dose/vial to 5 dose/vial. IRB approval has already been optained and baseline data collection began in Q4 2018. We propose to implement 3 arms of the study (5-dose vial and trainings, 10-dose vial and trainings, and control group) and measure the impact on immunization coverage during 2019-2020. The findings from this study will be highly relevant to other countries considering the cost and benefit of changing to a 5-dose measles vial.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">Consortium of Christian Relief and Development Associations (CCRDA) : Programme Management - General</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Conducted review meetings with religious leaders for 30 PP</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct  Review meeting on  EPI religious mainstreaming at woreda levels of Afar and Somali regions.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct  Review meeting on  EPI religious mainstreaming at woreda levels of Afar and Somali regions.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Monitor and evaluate the states of EPI data completeness and timeliness and increase by 40% from the baseline. Monitor and evaluate the states of EPI data and increase by 50% from the baseline. Monitor and evaluate the availability of monthly report and increase to 100% from the baseline.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct Routine data quality self-assessment in 8 woredas and 32 HFs twice a year in collaboration with Afar and Somali Regional Bureaus.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct Routine data quality self-assessment in 8 woredas and 32 HFs twice a year in collaboration with Afar and Somali Regional Bureaus.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Conducted 96 immunisation community Conversation (CC) cession in selected low coverage kebeles of Afar &amp; Somali region</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct community Conversation (CC) on immunisation at village (&apos;Got&apos;) level with the involvement of community leaders and Mothers/ Caretakers on monthly bases in   selected low coverage kebeles in 8 woredas of Afar &amp; Somali region">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct community Conversation (CC) on immunisation at village (&apos;Got&apos;) level with the involvement of community leaders and Mothers/ Caretakers on monthly bases in   selected low coverage kebeles in 8 woredas of Afar &amp; Somali region">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Conducted joint supportive supervision and follow up</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct joint supportive supervision to the health facility and community levels jointly with CGPP secretariat, PIPs and respective woreda health offices with the adopted Integrated supervision checklists and WHO QI tools.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct joint supportive supervision to the health facility and community levels jointly with CGPP secretariat, PIPs and respective woreda health offices with the adopted Integrated supervision checklists and WHO QI tools.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Conducted immunisation advocacy meeting in two zonal of Afar region.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct two days immunisation advocacy meeting at zonal level with political, clan and religious leaders of Afar &amp; Somali region">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct two days immunisation advocacy meeting at zonal level with political, clan and religious leaders of Afar &amp; Somali region">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Organized Mid and annual review meeting</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Organize Mid and annual review meeting with the project implementing partners and government staffs from each implementing region, zone and wordas to implementation progress, experience shirring and understand common cosines on the project activity.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Organize Mid and annual review meeting with the project implementing partners and government staffs from each implementing region, zone and wordas to implementation progress, experience shirring and understand common cosines on the project activity.">
      <location ref="ET"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Organize Mid and annual review meeting with the project implementing partners and government staffs from each implementing region, zone and wordas to implementation progress, experience shirring and understand common cosines on the project activity.">
      <location ref="ET"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">8 woredas, 10 HCs and 20 HP to be visited for the improved data management and utilisation for decision making at health facility and woreda health office</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide monthly data quality follow up in 8 woredas, 20 HCs and 110 HPs of Afar &amp; Somali regions to monitor over reporting or under reporting by using simple DQAS tool at facility and community levels.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide monthly data quality follow up in 8 woredas, 20 HCs and 110 HPs of Afar &amp; Somali regions to monitor over reporting or under reporting by using simple DQAS tool at facility and community levels.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Conducted three JSS/ISS on technical support on jobs and monitoring the states of demand and data quality activity</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct joint supportive supervision to the health facility and community levels jointly with PIPs filed officers and respective woreda health offices with the adopted Integrated supervision checklists and WHO QI tools.">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct joint supportive supervision to the health facility and community levels jointly with PIPs filed officers and respective woreda health offices with the adopted Integrated supervision checklists and WHO QI tools.">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">supported two EPI review meetings at woreda level</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Organize and support quarterly  EPI review meetings at woreda level  with the aim of identifying gaps and proposing local solution with the involvement of HEWs/HWs, woreda health offices, partners and members of woreda level EPI task force.">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Organize and support quarterly  EPI review meetings at woreda level  with the aim of identifying gaps and proposing local solution with the involvement of HEWs/HWs, woreda health offices, partners and members of woreda level EPI task force.">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">Consortium of Christian Relief and Development Associations (CCRDA) : Health Information Systems (Data)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">8 woredas, 10 HCs and 20 HP to be visited for the improved data management and utilization for decision making at health facility and woreda health office</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide Monthly routine data quality follow up in 8 woredas, 20 HCs and 110 HPs of Afar &amp; Somali regions to monitor over reporting or under reporting by using simple DQAS tool at facility and community levels.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide Monthly  routine data quality follow up in 8 woredas, 20 HCs and 110 HPs of Afar &amp; Somali  regions to monitor over reporting or under reporting by using simple DQAS tool at facility and community levels.">
      <location ref="ET"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide Monthly  routine data quality follow up in 8 woredas, 20 HCs and 110 HPs of Afar &amp; Somali  regions to monitor over reporting or under reporting by using simple DQAS tool at facility and community levels.">
      <location ref="ET"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">John Snow, Inc. : Programme Management - General</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Afar and Somali RHBs have a list of woredas with planned review meetings (incl PIRI/MCV2). Technical assistance provided to priority woredas for the preparation of PIRI/MCV2 related review meetings, including coaching/on-job support and guidance documents or templates as needed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Assist Afar and Somali RHBs in coordination and support regarding prep and follow-up of review meetings and provide technical assistance to select woredas conducting immunization (including PIRI/MCV2) review meetings.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Assist Afar and Somali RHBs in coordination and support regarding prep and follow-up of review meetings and provide technical assistance to select woredas conducting immunization (including PIRI/MCV2) review meetings.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Afar and Somali RHBs have mapped partners working on MCV2 and PIRI, and list partners by area of support and geography. Afar and Somali RHBs will organize a partners meeting and/or use existing coordination platforms to share situational analysis findings and develop a coordinated regional plan of action.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Mapping of partners and harmonization of implementation plans for PIRI/MCV2 in Afar and Somali regions.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Mapping of partners and harmonization of implementation plans for PIRI/MCV2 in Afar and Somali regions.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Document on partners mapping by geography and specific areas of support. MOH develops or adapts a simplified tool/checklist used to monitor and follow up implementation as per PIRI protocol and MCV2 rollout.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide a national level technical advisor to support MOH efforts in PIRI equity zones and developing regional states (DRS) with planning, implementation and monitoring of PIRI and MCV2, including strengthening links between MOH and DRS RHBs and developing guidance documents as needed.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide a national level technical advisor to support MOH efforts in PIRI equity zones and developing regional states (DRS) with planning, implementation and monitoring of PIRI and MCV2, including strengthening links between MOH and DRS RHBs and developing guidance documents as needed.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">MOH convenes partners to review progress to date on PIRI implementation, completion/timeliness of reporting, and other implementation issues.  Coordination/support visits conducted to priority RHBs.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide a national level technical advisor to support MOH efforts in PIRI equity zones and developing regional states (DRS) with planning, implementation and monitoring of PIRI and MCV2, including strengthening links between MOH and DRS RHBs and developing guidance documents as needed.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide a national level technical advisor to support MOH efforts in PIRI equity zones and developing regional states (DRS) with planning, implementation and monitoring of PIRI and MCV2, including strengthening links between MOH and DRS RHBs and developing guidance documents as needed.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Afar and Somali RHBs develop a capacity building plan utilizing findings of status review in coordination with partners</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical assistance to Afar and Somali RHBs in developing and monitoring a capacity building plan for woredas/PHCUs on PIRI/MCV2">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical assistance to Afar and Somali RHBs in developing and monitoring a capacity building plan for woredas/PHCUs on PIRI/MCV2">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Afar and Somali RHBs monitor capacity building plans and assess status using existing coordination and discussion mechanisms (e.g., technical working group meetings)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical assistance to Afar and Somali RHBs in developing and monitoring a capacity building plan for woredas/PHCUs on PIRI/MCV2.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical assistance to Afar and Somali RHBs in developing and monitoring a capacity building plan for woredas/PHCUs on PIRI/MCV2.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Afar and Somali RHBs have PIRI and MCV2 status reviewed and situation analysed and summarized into one report per region.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Review of PIRI and MCV2 performance status and situation analysis in Afar and Somali regions.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Review of PIRI and MCV2 performance status and situation analysis in Afar and Somali regions.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">PATH : Programme Implementation/Coverage &amp; Equity</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. One round supportive supervision conducted to health facilities and woreda health offices using checklist in all project woredas</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct program specific SS &amp; on job training (OJT) on EPI program in 8 project woredas of Afar and Somali regions   
- Develop comprehensive EPI checklist together with regional and woreda EPI team 
- Conduct supportive supervision using checklist 
- Provide onsite and written feedback">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct program specific SS &amp; on job training (OJT) on EPI program in 8 project woredas of Afar and Somali regions   
- Develop comprehensive EPI checklist together with regional and woreda EPI team 
- Conduct supportive supervision using checklist 
- Provide onsite and written feedback">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">2. Onsite and written feedback provided to all project woredas</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct program specific SS &amp; on job training (OJT) on EPI program in 8 project woredas of Afar and Somali regions   
- Develop comprehensive EPI checklist together with regional and woreda EPI team 
- Conduct supportive supervision using checklist 
- Provide onsite and written feedback">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct program specific SS &amp; on job training (OJT) on EPI program in 8 project woredas of Afar and Somali regions   
- Develop comprehensive EPI checklist together with regional and woreda EPI team 
- Conduct supportive supervision using checklist 
- Provide onsite and written feedback">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Comprehensive EPI checklist developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct program specific SS &amp; on job training (OJT) on EPI program in 8 project woredas of Afar and Somali regions - Develop comprehensive EPI checklist together with regional and woreda EPI team - Conduct supportive supervision using checklist - Provide onsite and written feedback - Identify and register unreached children under 2 years of age and pregnant women and register - Support PIRI implementation to vaccinate identified targets - Support monitoring of PIRI implementation status - Provide orientation on RED approach, PIRI strategy and RED micro-plan development processes - Support development of RED microplanning - Support monitoring of RED micro-plan utilization - Support revision of RED micro-plan">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1.Implementation of monthly session plan monitored monthly</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support RED micro-planning in 8 project woredas Afar and Somali regions  
- Provide orientation on RED approach, PIRI strategy and RED micro-plan development processes  
- Support development of RED microplanning  
- Support monitoring of RED micro-plan utilization  
- Support revision of RED micro-plan">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support RED micro-planning in 8 project woredas Afar and Somali regions  
- Provide orientation on RED approach, PIRI strategy and RED micro-plan development processes  
- Support development of RED microplanning  
- Support monitoring of RED micro-plan utilization  
- Support revision of RED micro-plan">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">2. Plan versus achievement monitored on quarterly basis</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support RED micro-planning in 8 project woredas Afar and Somali regions  
- Provide orientation on RED approach, PIRI strategy and RED micro-plan development processes  
- Support development of RED microplanning  
- Support monitoring of RED micro-plan utilization  
- Support revision of RED micro-plan">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support RED micro-planning in 8 project woredas Afar and Somali regions  
- Provide orientation on RED approach, PIRI strategy and RED micro-plan development processes  
- Support development of RED microplanning  
- Support monitoring of RED micro-plan utilization  
- Support revision of RED micro-plan">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">3. 80% of the project woredas revised their RED micro-plan bi-annually</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support RED micro-planning in 8 project woredas Afar and Somali regions  
- Provide orientation on RED approach, PIRI strategy and RED micro-plan development processes  
- Support development of RED microplanning  
- Support monitoring of RED micro-plan utilization  
- Support revision of RED micro-plan">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support RED micro-planning in 8 project woredas Afar and Somali regions  
- Provide orientation on RED approach, PIRI strategy and RED micro-plan development processes  
- Support development of RED microplanning  
- Support monitoring of RED micro-plan utilization  
- Support revision of RED micro-plan">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">80% of unreached children and pregnant women vaccinated in 8 project woredas</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the planning and implementation of PIRI in 8 project woredas of Afar and Somali regions  
- Identify and register unreached children under 2 years of age and pregnant women and register  
- Support PIRI implementation to vaccinate identified targets 
- Support monitoring of PIRI implementation status">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the planning and implementation of PIRI in 8 project woredas of Afar and Somali regions  
- Identify and register unreached children under 2 years of age and pregnant women and register  
- Support PIRI implementation to vaccinate identified targets 
- Support monitoring of PIRI implementation status">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">Acasus : Programme Management - LMC</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Finalised plan for the scale-up in the Amhara region</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Launch the program across the Amhara region from Sept 2021">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Analysis of remaining gaps in immunization activity and availability of critical inputs in target regions</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support to improve leadership, management and coordination of the immunisation programme">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support to improve leadership, management and coordination of the immunisation programme">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">December 2020: Presentations from National and Regional stocktakes (three regions)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support to improve leadership, management and coordination of the immunisation programme">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support to improve leadership, management and coordination of the immunisation programme">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">December 2020: Quarterly progress report</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support to improve leadership, management and coordination of the immunisation programme">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support to improve leadership, management and coordination of the immunisation programme">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Description of results from light support to other regions</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support to improve leadership, management and coordination of the immunisation programme">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support to improve leadership, management and coordination of the immunisation programme">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Final report from the project</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support to improve leadership, management and coordination of the immunisation programme">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support to improve leadership, management and coordination of the immunisation programme">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Implementation plan for the second household survey</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support to improve leadership, management and coordination of the immunisation programme">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support to improve leadership, management and coordination of the immunisation programme">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">March 2021: Quarterly progress report</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support to improve leadership, management and coordination of the immunisation programme">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support to improve leadership, management and coordination of the immunisation programme">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Presentations from National and Regional stocktakes (three regions)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support to improve leadership, management and coordination of the immunisation programme">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support to improve leadership, management and coordination of the immunisation programme">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Results and analysis from the second household survey</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support to improve leadership, management and coordination of the immunisation programme">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support to improve leadership, management and coordination of the immunisation programme">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Sustainability plan for the intervention</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support to improve leadership, management and coordination of the immunisation programme">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support to improve leadership, management and coordination of the immunisation programme">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Update note on activities completed in
the last 2 months</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support to improve leadership, management and coordination of the immunisation programme">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support to improve leadership, management and coordination of the immunisation programme">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Leadership, management, and coordination (LMC)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">EPI policy and cMYP completed and endorsed by NITAG and ICC</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Organize consultative workshop and write up meetings to discuss on and revise the current EPI policy, implementation guide and cMYP development and write up meetings">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Organize a consultative workshop to finalize the EPI policy, cMYP documents</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Organize consultative workshop and write up meetings to discuss on and revise the current EPI policy, implementation guide and cMYP development and write up meetings">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">100% of NITAG meetings held and 100% of NITAG recommendations implemented</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical Support NITAG/ICCC and EPI coordination mechanisms (TWGs) by meetings by preparing agendas, documents and prepare presentations and record recommendation: Support the training and field visits whenever possible">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical Support NITAG/ICCC and EPI coordination mechanisms (TWGs) by meetings by preparing agendas, documents and prepare presentations and record recommendation: Support the training and field visits whenever possible">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">PATH</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Participation in national 2nd Year implementation progress meetings completed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support to FMOH to monitor 2nd Year HPV dose 2 implemention progress, identify challenges, propose solutions">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">Consortium of Christian Relief and Development Associations (CCRDA) : Financial/General Management</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">At least 15 meetings held as per work plan and recommendations followed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support woreda EPI task force for local committee composed of Woreda Administration, Woreda Health Officer, Women and Children Affairs Officer, Religious and Clan Leaders, Immunization Partners and other relevant stake holders to monitor and evaluate the EPI program in 8 woredas of Afar and Somali region.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">60 percent of Micro planned activities implemented</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technically support and facilitate bottom up and doable RED/C micro planning at woreda level with the involvement of HEWs and Kebele administration and community representatives in 8 woredas and 80 percent of Micro planned activities implementation of Afar and Somali region.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">Clinton Health Access Initiative : Health Information Systems (Data)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">HPV data captured, compiled and report narrated and shared</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Timely Collection and Compilation of reports at National and subnational level and develop comprehensive technical report">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Timely Collection and Compilation of reports at National and subnational level and develop comprehensive technical report">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Health Information Systems (Data)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">80% zones, woredas and HFs improve data as measured by DQR and data triangulations (baseline ISS, DQS)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1.Conduct data triangulation workshop to estimate national and subnational immunization coverage estimates using global data triangulation guideline(s)">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1.Conduct data triangulation workshop to estimate national and subnational immunization coverage estimates using global data triangulation guideline(s)">
      <location ref="ET"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1.Conduct data triangulation workshop to estimate national and subnational immunization coverage estimates using global data triangulation guideline(s)">
      <location ref="ET"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">CDC Foundation : Vaccine-Specific Support</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">10 months of the measles 5 dose RCT implemented in study sites (across 60 woredas). Finalize field protocol for the endline survey.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Continue the implementation period, and carry out the endline survey for a study to examine the impact of the use of a 5 dose measles vaccine vial on measles coverage. CDC has been working with Ethiopia MoH, JSI, WHO, UNICEF, EPHI and RHBs to implement a randomized control study to document and measure the impact of reducing the measles vaccine vial size from a 10-dose vial to a 5-dose vial. The baseline is complete, and the study started implementation mid-December 2020 and will continue for 1 year. We are implementing 3 arms in the study (5-dose vial and trainings, 10-dose vial and trainings, and control group) and will measure the impact on immunization coverage pre and post implementation. The findings from this study will be highly relevant for Ethiopia and other countries considering changing to a 5-dose measles vial.">
      <location ref="ET"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Carry out a dissemination workshop on the barriers to MCV2 uptake in Oromia Region (across 18 woredas); supportive supervision in priority Zones focusing on MCV2; systematically assess the defaulter tracing mechanisms in the Region broadly</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Continued technical assistance in support of increasing MCV2 uptake in Ethiopia in Oromia Region, including a) programmatic support for strategies to increase uptake; b) support for increasing the quality of recording/reporting of vaccines doses delivered in 2YL; c) assessing strategies for improving defaulter tracing and, use of MCV2 as an opportunity for catch-up of children who missed their measles vaccination during the first year of life; d) communications messaging to increase awareness and demand for MCV2; e) capacity building for data quality assurance, analysis and triangulation of MCV1 &amp; MCV2 data, measles surveillance data and outbreak data at the district level); f) support field implementation of operations research on aforementioned topics">
      <location ref="ET"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Continued technical assistance in support of increasing MCV2 uptake in Ethiopia in Oromia Region, including
 a) programmatic support for strategies to increase uptake;
 b) support for increasing the quality of recording/reporting of vaccines doses delivered in 2YL;
 c) assessing strategies for improving defaulter tracing and, use of MCV2 as an opportunity for catch-up of children who missed their measles vaccination during the first year of life; 
d) communications messaging to increase awareness and demand for MCV2; 
e) capacity building for data quality assurance, analysis and triangulation of MCV1 &amp; MCV2 data, measles surveillance data and outbreak data at the district level); 
f) support field implementation of operations research on aforementioned topics">
      <location ref="ET"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Demand creation for MCV2 and RI; data triangulation for programatic use around MCV2 and RI; recommendations for reporting/recording quality improvements</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Continued technical assistance in support of increasing MCV2 uptake in Ethiopia in Oromia Region, including
 a) programmatic support for strategies to increase uptake;
 b) support for increasing the quality of recording/reporting of vaccines doses delivered in 2YL;
 c) assessing strategies for improving defaulter tracing and, use of MCV2 as an opportunity for catch-up of children who missed their measles vaccination during the first year of life; 
d) communications messaging to increase awareness and demand for MCV2; 
e) capacity building for data quality assurance, analysis and triangulation of MCV1 &amp; MCV2 data, measles surveillance data and outbreak data at the district level); 
f) support field implementation of operations research on aforementioned topics">
      <location ref="ET"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">6 months of the measles 5 dose RCT implemention completed in study sites (across 60 woredas). Interim report on progress at half way point of implementtaion.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Continue the implementation period, and carry out the endline survey for a study to examine the impact of the use of a 5 dose measles vaccine vial on measles coverage. CDC has been working with Ethiopia MoH, JSI, WHO, UNICEF, EPHI and RHBs to implement a randomized control study to document and measure the impact of reducing the measles vaccine vial size from a 10-dose vial to a 5-dose vial. The baseline is complete, and the study started implementation mid-December 2020 and will continue for 1 year. We are implementing 3 arms in the study (5-dose vial and trainings, 10-dose vial and trainings, and control group) and will measure the impact on immunization coverage pre and post implementation. The findings from this study will be highly relevant for Ethiopia and other countries considering changing to a 5-dose measles vial.">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Supply chain</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">CCE inventory performed/updated</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="CCE inventory data regularlly updated and rehabilitation plan developed/implemented for 85% of the national &amp; subnational (EPSA centre &amp; hubs) and 80% districts at 14 Unicef supported zones in three regions, quarterly. (Comment: Can make it clear and the CCEI is done recently by MoH and what is the importance of it)[Response:1.  Review CCEOP-ODP implementation /follow up the installation /commissioning and update the CCEI 
2. Rehabilitation ? follow up new CCE deployment and maintenance of the existing equipment progress  ]">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="CCE inventory data regularlly updated and rehabilitation plan developed/implemented for 85% of the national &amp; subnational (EPSA centre &amp; hubs) and 80% districts at 14 Unicef supported zones in three regions, quarterly. (Comment: Can make it clear and the CCEI is done recently by MoH and what is the importance of it)[Response:1.  Review CCEOP-ODP implementation /follow up the installation /commissioning and update the CCEI 
2. Rehabilitation ? follow up new CCE deployment and maintenance of the existing equipment progress  ]">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">EVMA performed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conducted EVMA self-assessment in 85% of EPSA centre and hubs and 80% of districts at the 14 UNICEF supported zones, EVM Improvement plan developed; and attain EVM indicator for temperature (E2) at least 80% in 85% of the targets once in a year.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conducted EVMA self-assessment in 85% of EPSA centre and hubs and 80% of districts at the 14 UNICEF supported zones, EVM Improvement plan developed; and attain EVM indicator for temperature (E2) at least 80% in 85% of the targets once in a year.">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Data desk review or triangulation analysis performed (coverage, surveillance, operational, others)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Triangulatation conducted on vaccine stock and performance, administrataive data validated and feedback provided quarterly in 80% of woredas in 14 UNICEF supported zones in Amhara, Oromia and SNNP Regions.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Triangulatation conducted on vaccine stock and performance, administrataive data validated and feedback provided quarterly in 80% of woredas in 14 UNICEF supported zones in Amhara, Oromia and SNNP Regions.">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Remote data collection platform implemented</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Monitor stock data and provide feedback for 85% of districts in the 14 UNICEF supported zones who are using mBrana quarterly. (Comment: is that supervision or feedback) - [Respon. mBrana data accessed remotely, analyzed and feedback provided to assessed districts. Supervision and workshop will be conducted to enhance and reinforce mBrana utilization.]">
      <location ref="ET"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Monitor stock data and provide feedback for 85% of districts in the 14 UNICEF supported zones who are using mBrana quarterly. (Comment: is that supervision or feedback) - [Respon. mBrana data accessed remotely, analyzed and feedback provided to assessed districts. Supervision and workshop will be conducted to enhance and reinforce mBrana utilization.]">
      <location ref="ET"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Monitor stock data and provide feedback for 85% of districts in the 14 UNICEF supported zones who are using mBrana quarterly. (Comment: is that supervision or feedback) - [Respon. mBrana data accessed remotely, analyzed and feedback provided to assessed districts. Supervision and workshop will be conducted to enhance and reinforce mBrana utilization.]">
      <location ref="ET"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Human Resources for Health</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Post training supportive supervision and review meeting in 40-60% of health facilities in the selected zones will be conducted</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct two rounds of annual post training supportive supervision and review meetings in the priority zones">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">40-60% of trained health workers will develop operational micro planning including session planning to reach more &apos;0&apos; dose children in the selected zones</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support training of health care workers in 12 priority zones in three big regions (Tigray, Amhara, Oromia) and one Benishangul Gumz region and , Addis Ababa and Dire Dawa City Administrations. (1) Train 100-120 Regions and EPI focals and experts on MLM (online and virtual and in persons) (2) Train 380-400 EPI experts working in health care facilities in Combined RED/IIP training and other Immunization in Actions interactive training">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">One person from EPI case team trained in advanced vaccinology training abroad</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support one person from the MoH/EPI for vaccinology course abroad">
      <location ref="ET"></location>
     </target>
     <actual value="Major Delays">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support one person from the MoH/EPI for vaccinology course abroad">
      <location ref="ET"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">System for regular monitoring and supervision of vaccinators / FHWs in priority areas is in place, allowing for assessing trend in performance</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct two rounds of annual post training supportive supervision and review meetings in the priority zones">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct two rounds of annual post training supportive supervision and review meetings in the priority zones">
      <location ref="ET"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Identification of the institute and ensure admission for the course</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support one person from the MoH/EPI for vaccinology course abroad">
      <location ref="ET"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Trained health workers will developing operational MP and session planning to improve service delivery in their catchment areas</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support training of health care workers in 12 priority zones in three big regions (Tigray, Amhara, Oromia) and one Benishangul Gumz region and , Addis Ababa and Dire Dawa City Administrations. (1) Train 100-120 Regions and EPI focals and experts on MLM (online and virtual and in persons) (2) Train 380-400 EPI experts working in health care facilities in Combined RED/IIP training and other Immunization in Actions interactive training">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Vaccine-Specific Support</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">AEFI causality assessments conducted</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support biannual meeting of national AEFI committees and national stakeholders ( EPI, NRA and partners).Provide Technical and financial support to Investigation of serious AEFI cases in the field">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Develop concept notes and proposals and share with FMoH for endorsement</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct MOV assessment in selected zones to determine the magnitude and reasons of MOV so that to guide policy changes and design MOV interventions for improving EPI coverage and reducing inequities">
      <location ref="ET"></location>
     </target>
     <actual value="Major Delays">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&gt;80% Health facilities (health posts) in the targeted zones and urban slums developed session plans and vaccine requirements and monitor the conduct of sessions (Micro-planning)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1.Support training of health workers on the MLM, Combined RED/IIP  focusing on (2YL) to  new 8 priority zones in four big regions (Tigray, Amhara, Oromia, and SNNPR) and health workers health workers from Health facilities with underserved catchment areas in Addis Ababa and Diredawa City Administrations (urban inequalities)">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1.Support training of health workers on the MLM, Combined RED/IIP  focusing on (2YL) to  new 8 priority zones in four big regions (Tigray, Amhara, Oromia, and SNNPR) and health workers health workers from Health facilities with underserved catchment areas in Addis Ababa and Diredawa City Administrations (urban inequalities)">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">AEFI platform implemented</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support biannual meeting of national AEFI committees and national stakeholders ( EPI, NRA and partners).Provide Technical and financial support to Investigation of serious AEFI cases in the field">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">conduct MOV assessment in the selected zones to determine factors contributing to the missed children and community</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct MOV assessment in selected zones to determine the magnitude and reasons of MOV so that to guide policy changes and design MOV interventions for improving EPI coverage and reducing inequities">
      <location ref="ET"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">80% of severe AEFI cases classified</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="4.Support biannual &#xA0;meeting of national AEFI committees &#xA0;and national stakeholders ( EPI, NRA and partners).Provide Technical and financial support to Investigation of serious AEFI cases in the field">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="4.Support biannual &#xA0;meeting of national AEFI committees &#xA0;and national stakeholders ( EPI, NRA and partners).Provide Technical and financial support to Investigation of serious AEFI cases in the field">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Reach &gt;95% of targeted children</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="5.    Provide technical support to implement:                                                                                                                                                        ?   PIRI in the targeted zones                                                                                                                                                                              ?    AVW in the targeted zones                                                                                                                                     ?   roll out of MCV2 to all health facilities and implementation of HPV vaccinations in the big four regions">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="5.    Provide technical support to implement:                                                                                                                                                        ?   PIRI in the targeted zones                                                                                                                                                                              ?    AVW in the targeted zones                                                                                                                                     ?   roll out of MCV2 to all health facilities and implementation of HPV vaccinations in the big four regions">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Dissemination workshop</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="3.Conduct Dropouts/MOV assessment in selected zones to determine the magnitude and reasons ofDropouts/ MOV so that to guide policy changes and design MOV interventions for improving EPI coverage and reducing inequities">
      <location ref="ET"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="3.Conduct Dropouts/MOV assessment in selected zones to determine the magnitude and reasons ofDropouts/ MOV so that to guide policy changes and design MOV interventions for improving EPI coverage and reducing inequities">
      <location ref="ET"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">Consortium of Christian Relief and Development Associations (CCRDA) : Demand Promotion &amp; ACSM</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Conducted 90 immunization community Conversation (CC) cession  in   selected low coverage kebeles  of Afar &amp; Somali region</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct community Conversation (CC) on immunization at village (&apos;Got&apos;) level with the involvement of community leaders and Mothers/Caretakers on monthly bases in   selected low coverage kebeles in 8 woredas of Afar &amp; Somali region">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct community Conversation (CC) on immunization at village (&apos;Got&apos;) level with the involvement of community leaders and Mothers/Caretakers on monthly bases in   selected low coverage kebeles in 8 woredas of Afar &amp; Somali region">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Conducted final project assessment and evaluation survey</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Final project assessment and evaluation survey using WHO 30X10 cluster sampling method of data quality and demand generation in 8 woredas of Afar and Somali regions.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Final project assessment and evaluation survey using WHO 30X10 cluster sampling method of data quality and demand generation in 8 woredas of Afar and Somali regions.">
      <location ref="ET"></location>
     </target>
     <actual value="Major Delays">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Final project assessment and evaluation survey using WHO 30X10 cluster sampling method of data quality and demand generation in 8 woredas of Afar and Somali regions.">
      <location ref="ET"></location>
     </target>
     <actual value="Major Delays">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Provided refresher training for community conversation facilitation in 30 low preforming kebeles (30 HEWs trained) of Afar &amp; Somali region.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide refresher training for HEWs/ HWs on community conversation facilitation in 8 woredas of Afar &amp; Somali region">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Supported woreda EPI task force for the  first two quarters in 8 woredas.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support woreda EPI task force for local committee composed of Woreda Administration, Woreda Health Office, Women and Children Affair, Religious and Clan Leaders, Immunization Partners and other relevant stake holders to monitor and evaluate the EPI program in 8 woredas of Afar and Somali region.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support woreda EPI task force for local committee composed of Woreda Administration, Woreda Health Office, Women and Children Affair, Religious and Clan Leaders, Immunization Partners and other relevant stake holders to monitor and evaluate the EPI program in 8 woredas of Afar and Somali region.">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Conducted 30 immunization community Conversation (CC) cession in selected low coverage kebeles of Afar &amp; Somali region</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct community Conversation (CC) on immunization at village (&apos;Got&apos;) level with the involvement of community leaders and Mothers/Caretakers on monthly bases in selected low coverage kebeles in 8 woredas of Afar &amp; Somali region">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Leadership, management, and coordination (LMC)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Equity or Accessibility assessment performed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="EPI performance review and/or MSD supported and  progress documented">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">In-depth assessement of data quality (DQR, DQA, audit) performed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="EPI performance review and/or MSD supported and  progress documented">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Complete of implementation period (runs in total for 16 months), and reporting on status. Carry out endline survey.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Missed opportunities for vaccination due to healthcare worker reluctance to open a multi-dose vial is well described in the literature.   CDC has been working with Ethiopia FMoH and immunization partners to design and implement a randomized control study to document and measure the impact of reduce Measles vial size from 10 dose/vial to 5 dose/vial.  IRB approval has already been optained and baseline data collection is planned to begin Q4 2019.  We propose to continue to implement the 3 arms of the study (5-dose vial and trainings, 10-dose vial and trainings, and control group) and measure the impact on immunization coverage during 2020-2021. The funds identified are the anticipated needs to complete the full implementation, which will begin Q2 2020 with funds already recieved under the last TCA cycle. The findings from this study will be highly relevant to other countries considering the cost and benefit of changing to a 5-dose measles vial.">
      <location ref="ET"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Missed opportunities for vaccination due to healthcare worker reluctance to open a multi-dose vial is well described in the literature.   CDC has been working with Ethiopia FMoH and immunization partners to design and implement a randomized control study to document and measure the impact of reduce Measles vial size from 10 dose/vial to 5 dose/vial.  IRB approval has already been optained and baseline data collection is planned to begin Q4 2019.  We propose to continue to implement the 3 arms of the study (5-dose vial and trainings, 10-dose vial and trainings, and control group) and measure the impact on immunization coverage during 2020-2021. The funds identified are the anticipated needs to complete the full implementation, which will begin Q2 2020 with funds already recieved under the last TCA cycle. The findings from this study will be highly relevant to other countries considering the cost and benefit of changing to a 5-dose measles vial.">
      <location ref="ET"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Missed opportunities for vaccination due to healthcare worker reluctance to open a multi-dose vial is well described in the literature. CDC has been working with Ethiopia FMoH and immunization partners to design and implement a randomized control study to document and measure the impact of reduce Measles vial size from 10 dose/vial to 5 dose/vial. IRB approval has already been optained and baseline data collection is planned to begin Q4 2019. We propose to continue to implement the 3 arms of the study (5-dose vial and trainings, 10-dose vial and trainings, and control group) and measure the impact on immunization coverage during 2020-2021. The funds identified are the anticipated needs to complete the full implementation, which will begin Q2 2020 with funds already recieved under the last TCA cycle. The findings from this study will be highly relevant to other countries considering the cost and benefit of changing to a 5-dose measles vial.">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Complete a further 6 months of the implementation phase initiated in selected zones</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Missed opportunities for vaccination due to healthcare worker reluctance to open a multi-dose vial is well described in the literature. CDC has been working with Ethiopia FMoH and immunization partners to design and implement a randomized control study to document and measure the impact of reduce Measles vial size from 10 dose/vial to 5 dose/vial. IRB approval has already been optained and baseline data collection is planned to begin Q4 2019. We propose to continue to implement the 3 arms of the study (5-dose vial and trainings, 10-dose vial and trainings, and control group) and measure the impact on immunization coverage during 2020-2021. The funds identified are the anticipated needs to complete the full implementation, which will begin Q2 2020 with funds already recieved under the last TCA cycle. The findings from this study will be highly relevant to other countries considering the cost and benefit of changing to a 5-dose measles vial.">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Demand Promotion &amp; ACSM</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">three Community engagement strategy for high risk communties is implemented in 14 zones in Amhara,SNNPR and oromia</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Enhance community engagement in the UNICEF supported 14 zones of three large regions and Addis Ababa to increase immunization uptake Key activities 1 Develop and implement tailored behavior and social changes strategy for remote rural, urban scattered communities , conflict affected and communities with low socio-economic status and implementation in 14 zones in Amhara Oromia and SNNPR 2. Monitoring of community participation, especially of women, in the planning and monitoring of immunization sessions in the framework of the RED/REC 3. Strengthen SBCC coordination at regional level and in 14 UNICEF targeted zones, among programmes, particularly of EPI and HEP, and partners including women networks and other local CSOs; 4. Support MCV2 , Measles SIA and NVI roll out in communication planning, development/adjustment of communication tools, and monitoring">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Plan to overcome vaccine demand-related barriers in high risk communities developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Capacity building of EPI/health promotion officers from prioritized zones of Amhara, Oromia and SNNP on Human Centered Design Thinking approach for contextualized immunization demand generation">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Capacity building of EPI/health promotion officers from prioritized zones of Amhara, Oromia and SNNP on Human Centered Design Thinking approach for contextualized immunization demand generation">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Prototyping of demand generation intervention by using human centered design thinking approach in peri-urban communities of Oromia which has highest number of zero-dosed children">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">MCV2, measles, SIA and NVI communication tools available at the regional level</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Enhance community engagement in the UNICEF supported 14 zones of three large regions and Addis Ababa to increase immunization uptake

Key activities
1 Develop and implement tailored behavior and social changes strategy for  remote rural, urban  scattered communities , conflict affected and communities with low socio-economic status and   implementation in 14 zones  in Amhara   Oromia and SNNPR  

 2. Monitoring of community participation, especially of women, in the planning and monitoring of immunization sessions in the framework of the RED/REC

3. Strengthen SBCC coordination at regional level  and  in 14   UNICEF targeted zones, among programmes, particularly of EPI and HEP, and partners including women networks and other local CSOs; 

4. Support  MCV2 , Measles SIA and NVI   roll out in communication planning, development/adjustment of communication tools, and monitoring">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Enhance community engagement in the UNICEF supported 14 zones of three large regions and Addis Ababa to increase immunization uptake

Key activities
1 Develop and implement tailored behavior and social changes strategy for  remote rural, urban  scattered communities , conflict affected and communities with low socio-economic status and   implementation in 14 zones  in Amhara   Oromia and SNNPR  

 2. Monitoring of community participation, especially of women, in the planning and monitoring of immunization sessions in the framework of the RED/REC

3. Strengthen SBCC coordination at regional level  and  in 14   UNICEF targeted zones, among programmes, particularly of EPI and HEP, and partners including women networks and other local CSOs; 

4. Support  MCV2 , Measles SIA and NVI   roll out in communication planning, development/adjustment of communication tools, and monitoring">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Implementation of C4I activities at the community level in the prioritized zones are monitored.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Monitoring on the implementation of community engagement activities in prioritized zones of Amhara, SNNP and Oromia especially on the participation of women, in the planning and monitoring of immunization sessions in the framework of the RED/REC">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Risk communication plan developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support EPI on development of crisis/risk communication plan of action on routine immunization and new vaccine introduction such as nOPV2 (Comment: I thought this was planned by Covax/Gavi TCA so what makes it different | Reply: This will be for routine immunizatio nand nOPV2.">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">PATH : Vaccine-Specific Support</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Assist regions to send HPV performance report through DHIS2</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Assist routinizing HPV report through DHIS 2 by reporting in to routine HIS">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">MSD/JA report and One TA Plan finalized</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Assist successful Gavi joint appraisal/MSD meetings by organizing One TA/MSD report finalization workshop">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">One woreda selected per region</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Capacity buidling training for HCWs in creation of model woreda on service provision &amp; data quality">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Virtual orientation provided</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct on site support during HPV campaign and assist virtual orientation. Technical Assistance and Vehicle support for a HPV campaign by maintaining infection prevention and control principles.">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Participate on national and regional WGs and assist planning and implementation of SBCC work</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Participation in advocacy and coordination between national &amp; regional levels in Afar and Somali">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Participate on national and regional TWGs</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Participation in national TWG, M&amp;E task force and Training task force for 4th year HPV planning and preparation">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Improved HPV coverage</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical assistance to implemention recommendations from HPV PIE">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Service Delivery</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Advocacy (review) workshops will be conducted at the four regions involving the selected zones to aware them about the interventions</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Organize a two days advocacy workshops both at national and regional levels, in the four regions to identify &apos;0&quot; dose children, missed communities and identify priority zones for support: Participants are from Regional MCH, EPI experts from Zones and woredas: drafts a micro planning and work plan to reach the missed communities.">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Health workers in the selected zones will support the effort to identify &apos;0&apos;dose children &amp; unreached communities in their catchment areas</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Organize a two days advocacy workshops both at national and regional levels, in the four regions to identify &apos;0&quot; dose children, missed communities and identify priority zones for support: Participants are from Regional MCH, EPI experts from Zones and woredas: drafts a micro planning and work plan to reach the missed communities.">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Support NVI, PIRI, multiantigen catch-up campaigns as requested by FMoH and RHBs</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical support to implement: ? 
 ? PIRI in the targeted zones 
 ? AVW
 ? New vaccine introduction (IPV2, COVID-19 vaccine, nOPV2, Yellow fever, MRV and MenAfric A)
 ? SIA
 ? Roll out of C-19 and HPV vaccinations in the big four regions">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">prepare concept notes, proposals and workplan, assess readiness and monitor implementation and post implementation of the exercises</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical support to implement: ? 
 ? PIRI in the targeted zones 
 ? AVW
 ? New vaccine introduction (IPV2, COVID-19 vaccine, nOPV2, Yellow fever, MRV and MenAfric A)
 ? SIA
 ? Roll out of C-19 and HPV vaccinations in the big four regions">
      <location ref="ET"></location>
     </target>
     <actual value="On Track">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">CDC</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Annual review meeting held</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Strengthen Congenital Rubella Syndrome (CRS) Surveillance">
      <location ref="ET"></location>
     </target>
     <actual value="Major Delays">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">completed readiness assessment from at least 2 sub-districts and/or 2 districts; completed independent monitoring forms/analysis from at least 5 vaccination sites; completed RCM in at least 5 catchment areas</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1 CDC staff to provide TA for 30 days to ensure high quality preparation, implementation and monitoring for measles follow up SIA planned in QTR 4 2019">
      <location ref="ET"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">University of Oslo : Data</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Covid-19 digital package installed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support planning, configuration and management of COVID-19 surveillance">
      <location ref="ET"></location>
     </target>
     <actual value="Completed">
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">5. EPI Legacy data migrated (if fully transitioned) 8. Scorecard app installed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support activities enhancing data analysis and use">
      <location ref="ET"></location>
     </target>
     <actual>
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">5. EPI Legacy data migrated (if fully transitioned)
8. Scorecard app installed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support activities enhancing data analysis and use">
      <location ref="ET"></location>
     </target>
     <actual>
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Core team trained on planned digital data package or app and know how to use it
Costed scale up plan exist</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support activities enhancing data analysis and use">
      <location ref="ET"></location>
     </target>
     <actual>
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Core team trained on COVID-19 digital data package and know how to use it.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support planning, configuration and management of COVID-19 surveillance">
      <location ref="ET"></location>
     </target>
     <actual>
      <location ref="ET"></location>
     </actual>
    </period>
   </indicator>
  </result>
 </iati-activity>
</iati-activities>
